New dialysis method to remove protein-bound toxins
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing a new way to do hemodialysis to better remove waste products that build up in the blood. It may help improve dialysis treatment for people with kidney failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be on hemodialysis 3 times a week for 4 hours each time, for at least 3 months.
- If you can become pregnant, you must use effective birth control during the study.
- You must have very little urine output (less than 100 mL per day).
- You must not be allergic to eggs, soy, or peanuts.
- Your blood pressure must be well controlled and you must not have recent low blood pressure during dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
This study tests whether dialysis can be done safely without using heparin (a blood thinner) in people with end-stage kidney disease. If successful, it could reduce the need for blood-thinning medications and their associated risks.
This study looks at how different types of dialysis affect salt stored in your tissues and your small blood vessels. It may help doctors understand how to improve dialysis treatments.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
This study tests whether adding a special blood-cleaning treatment called hemoperfusion to regular dialysis can improve health outcomes for people with kidney failure. It aims to see if this extra treatment helps patients feel better and live longer.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.